![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Real-life effectiveness and safety of
Glecaprevir/Pibrentasvir in HCV-infected patients
with chronic kidney disease
|
|
|
Reported by Jules Levin
EASL 219 April 10-14 Vienna
M. PERSICO1, A. AGLITTI1, R. CARUSO1, G. CALVANESE1, P. DI SIERVI1, M. MASARONE1
1Department of Medicine and Surgery - Internal Medicine and Hepatology Unit, University of Salerno, Italy
![0422191](../images/042219/042219-6/0422191.gif)
![0422192](../images/042219/042219-6/0422192.gif)
![0422193](../images/042219/042219-6/0422193.gif)
![0422194](../images/042219/042219-6/0422194.gif)
![0422195](../images/042219/042219-6/0422195.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|